| 今开：1.4 | 昨收：1.41 |
| 最高：1.44 | 最低：1.315 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.6398126E7 |
Cue Biopharma(CUE)02-08 06:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006803 Act: 34 Size: 12 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028609 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:35
$Cue Biopharma(CUE)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-24-038084 Act: 33 Size: 146 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028612 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028608 Size: 5 KB 网页链接查看全文
Cue Biopharma(CUE)02-01 03:15
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-006036 Act: 34 Size: 13 KB 网页链接查看全文
Cue Biopharma(CUE)04-27 04:05
$Cue Biopharma(CUE)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-049072 Act: 34 Size: 1 MB 网页链接查看全文
Cue Biopharma(CUE)03-12 06:45
$Cue生物制药(CUE)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001781002-24-000025 Act: 34 Size: 41 KB 网页链接查看全文
Cue Biopharma(CUE)03-29 04:45
$Cue Biopharma(CUE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-038059 Act: 34 Size: 12 MB 网页链接查看全文
Cue Biopharma(CUE)03-09 05:05
$Cue生物制药(CUE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-028613 Size: 5 KB 网页链接查看全文
$Cue生物制药(CUE)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-02-08 AccNo: 0001193125-19-032256 Size: 229 KB 网页链接
$Cue生物制药(CUE)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2019-01-14 AccNo: 0001193125-19-009008 Size: 78 KB 网页链接
$Cue生物制药(CUE)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2019-01-04 AccNo: 0001193125-19-002594 Size: 759 KB 网页链接
$Cue生物制药(CUE)$ 8-K/A [Amend] - Current report Filed: 2018-12-26 AccNo: 0001193125-18-358131 Size: 848 KBItem 1.01: Entry into a Material Definitive AgreementItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cue Biopharma, Inc.(CUE)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-13 AccNo: 0001564590-18-029316 Size: 4 MB 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K/A [Amend] - Current report Filed: 2018-11-13 AccNo: 0001193125-18-325520 Size: 789 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Cue Biopharma, Inc.(CUE)$ 8-K - Current report Filed: 2018-11-08 AccNo: 0001193125-18-321949 Size: 50 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...
$Cue Biopharma, Inc.(CUE)$ CORRESP [Cover] - Correspondence Filed: 2018-07-17 AccNo: 0001193125-18-219367 Size: 4 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ CORRESP [Cover] - Correspondence Filed: 2018-07-13 AccNo: 0001193125-18-217917 Size: 12 KB 网页链接
$Cue Biopharma, Inc.(CUE)$ UPLOAD [Cover] - SEC-generated letter Filed: 2018-07-03 AccNo: 0000000000-18-020490 Size: 40 KB 网页链接